NCT03912792

Brief Summary

The proposed natural history study will enroll male patients with a diagnosis of XLHED, female carriers of XLHED and healthy volunteers. The study protocol will include collection of XLHED questionnaires and clinical outcomes using minimally invasive technologies. Data will be collected both retrospectively and prospectively. Clinical outcome assessments will be performed at the NFED Family Conference on July 11-12, 2019. Study participants will be able to complete XLHED questionnaires electronically ahead of the conference.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 11, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

June 28, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

July 2, 2019

Status Verified

June 1, 2019

Enrollment Period

2 months

First QC Date

April 10, 2019

Last Update Submit

June 28, 2019

Conditions

Keywords

Natural History StudyX-Linked Hypohidrotic Ectodermal Dysplasia

Outcome Measures

Primary Outcomes (1)

  • The volume of sweat from a pilocarpine-induced sweat test

    Day 1

Study Arms (2)

XLHED Patients

Healthy Controls

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Males with XLHED and female carriers of XLHED Male and female healthy volunteers

You may qualify if:

  • Informed Consent
  • Males with XLHED, female carriers of XLHED and healthy volunteers

You may not qualify if:

  • Treatment with an investigational study drug for XLHED
  • Any major medical problems that would prevent her/him from participating in this study
  • Known hypersensitivity to pilocarpine or pilocarpine-like muscarinic agonists (Examples: Urecholine, Salagen, Pilocar, and Provocholine)
  • Pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chicago Marriott Lincolnshire Resort

Lincolnshire, Illinois, 60069, United States

Location

MeSH Terms

Conditions

Ectodermal Dysplasia 1, Anhidrotic

Condition Hierarchy (Ancestors)

Ectodermal DysplasiaAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin AbnormalitiesGenetic Diseases, X-LinkedGenetic Diseases, InbornSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Dorothy K Grange, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2019

First Posted

April 11, 2019

Study Start

June 28, 2019

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

July 2, 2019

Record last verified: 2019-06

Locations